Recent posts

Webinar Highlights – Pharmacopeial Modernization: How Will Your Chromatography Workflow Benefit?

By October 17, 2018

Waters recently partnered with United States Pharmacopeia (USP) experts to host a webinar discussing the upcoming changes in the pending USP General Chapter on chromatography that will provide increased flexibility for gradient methods. Here’s an extended Q&A from the webinar.

Categories: Pharmaceutical
Tags: , , , , , ,

I Resolve to Get Better mAb Separations

By August 8, 2018

We listened and learned how scientists separate mAbs and ADCs; then we designed a novel column for LC-MS bioseparations A critical step toward the prolific and successful use of monoclonal antibodies (mAb) as biotherapeutics occurred… Read more >

Categories: Columns
Tags: , , , , , , , ,

Data Integrity Matters | What do you do with Orphan Data Created during Data Acquisition?

By July 19, 2018

Halting a chromatographic analysis where the system is not performing correctly or when another error is evident in the separation is a valuable and scientific way to avoid creating unusable data that needs to be subsequently invalidated following a defined analytical lab error/result SOP. But what do you do with that orphan data?

Categories: Data Integrity
Tags: , , , , , ,

UPLC Chromatography Gets an Update: Because Science Never Quits

By April 27, 2018

We’ve updated our UPLC systems to enable you to find faster, simpler, and better ways to do your work. Take a closer look at our new and improved ACQUITY UPLC PLUS Series.

Categories: Technologies
Tags: , , , , , , , , , , ,

How Do Food Safety Laboratories Test for Acrylamide?

By March 30, 2018

Q&A time: What is acrylamide? How dangerous is it? How do food testing laboratories detect it?

Categories: Food & Environmental
Tags: , , , , , , ,

The Waters ACQUITY Arc System Receives 2016 Frost & Sullivan New Product Innovation Award

By October 4, 2016

Bridging the gap between HPLC and UPLC performance, the ACQUITY Arc System is a favorite of QC laboratories that test small and large molecule pharmaceuticals. We’re excited to announce today (Tuesday, Oct. 5) that our… Read more >

Categories: Technologies
Tags: , , , ,

Three Reasons for Biopharmaceutical Labs to Add Mass Detection to Routine Analyses

By March 9, 2016

As regulators focus in on the critical quality attributes of biotherapeutics, what can biopharmaceutical labs in late development or QC do to increase confidence in their bioseparations – other than to run more assays?

Categories: Pharmaceutical, Technologies
Tags: , , , , , , , , , , , , , , , , , ,